Paying for statins
Open Access
- 12 February 2004
- Vol. 328 (7436) , 400-402
- https://doi.org/10.1136/bmj.328.7436.400
Abstract
Should UK general practitioners be able to offer private prescriptions for statins to patients below 3% risk of heart disease?Keywords
This publication has 9 references indexed in Scilit:
- Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysisBMJ, 2003
- Population implications of lipid lowering for prevention of coronary heart disease: data from the 1995 Scottish health surveyHeart, 2001
- Statins: underused by those who would benefitBMJ, 2000
- Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trialsBMJ, 2000
- Guidelines on preventing cardiovascular disease in clinical practiceBMJ, 2000
- Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.Health Technology Assessment, 2000
- Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatmentHeart, 1999
- Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.1998
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998